Health Professional Radio - Podcast

Kate Rosenbluth, PhD, Chief Scientific Officer at Cala Health discusses the impact of patients living with essential tremors (ET). She talks about the inner workings of the Cala Trio™, a new, wrist-worn bioelectronic device, that is the only non-invasive, non-drug therapy that goes directly to the source of tremor by delivering advanced targeted therapy that safely and effectively reduces hand tremors. This new approach harnesses the advances in neuroscience, nerve excitation, and electronics miniaturization and decades of neuromodulation experience to improve care for patients with ET.